⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024

[Quantitative Detection and Integrality Analysis of Plasma Circulating Cell-Free DNA in Multiple Myeloma].

Lan-Xin Zhang Yizhi Jiang Lijun Qiu Dongping Huang

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the role of plasma circulating cell-free DNA (cf-DNA) in the screening and diagnosis of patients with newly diagnosed multiple myeloma (MM) and explore the changes of cf-DNA in terms of content and integrality in the assessment of disease in patients treated with chemotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e5e2bab6db6435875774a6 https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.020

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Integrated cell-free DNA and RNA sequencing recapitulates bone marrow genomic and transcriptomic alterations in multiple myeloma2025 · 1 citations
2Circulating Tumor DNA As a Minimally Invasive Predictor of Early Relapse in Multiple Myeloma2024 · 2 citations
3Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study2024 · 5 citations
4Liquid biopsy for non-invasive molecular characterization and measurable residual disease analysis in multiple myeloma2025
5Circulating Tumor DNA in Multiple Myeloma: Current Insights and Future PerspectivesOriginal Research · 2026

More related papers

Detection and classification of lymphoma from cell-free methylome data2026
Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights2026
Pilot study of cell-free DNA (cfDNA) for measurable residual disease monitoring following autologous hematopoietic cell transplant in multiple myeloma2025